Atovaquone Suspension
Product Images NDC 70166-488

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Atovaquone (NDC 70166-488). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lohxa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Atovaquoneoscartonlabel (Atovaquonecup 20191219 204246)

Atovaquone oral suspension 750 mg/5 mL label shows the product for oral use only, with instructions to shake gently before using and sip entire contents. The label includes dosage strength, unit volume (50 units x 5 mL), storage instructions to keep at controlled room temperature 20 to 25°C and not to freeze. The product is repackaged by Lohxa, Worcester, MA, with the Lohxa logo and website displayed.*

FDA Label Image

Atovaquonestructure (Atovaquonestructure)

Chemical structure of atovaquone, showing its molecular framework with specific functional groups including a chlorophenyl moiety and quinone structure.*

FDA Label Image

Address1 (Address1)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.